These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 808999)

  • 1. Current concepts of the formation and composition of amyloid.
    Glenner GG
    Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid fibril protein related to immunoglobulin lambda-chains.
    Skinner M; Benson MD; Cohen AS
    J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of "amyloid" fibrils from Bence Jones proteins in vitro.
    Glenner GG; Ein D; Eanes ED; Bladen HA; Terry W; Page DL
    Science; 1971 Nov; 174(4010):712-4. PubMed ID: 5123421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyloidosis of the A-kappa type].
    Scherwitz C; Linke RP; Schmitt FJ
    Hautarzt; 1986 Jun; 37(6):343-6. PubMed ID: 3087912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
    Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
    Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of the immunoglobulin origin of amyloid fibrils and its pathogenetic significance.
    Glenner GG
    Acta Pathol Microbiol Scand Suppl; 1972; 233():114-21. PubMed ID: 5074621
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins.
    White GC; Jacobson RJ; Binder RA; Linke RP; Glenner GG
    Blood; 1975 Nov; 46(5):713-22. PubMed ID: 809071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid fibril proteins found in Papua New Guinean and other amyloidoses.
    Anders RF
    P N G Med J; 1978 Mar; 21(1):79-85. PubMed ID: 286487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyloidosis. I. Recent findings concerning amyloid substance].
    Lovisetto P; Gilardi E; Frascisco M; Marchi L; Mairano D
    Minerva Med; 1980 Jun; 71(25):1793-800. PubMed ID: 6997780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
    Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
    Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary structure of the variable region of a human lambda VI light chain: Bence Jones protein SUT.
    Frangione B; Moloshok T; Solomon A
    J Immunol; 1983 Nov; 131(5):2490-3. PubMed ID: 6415173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
    Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
    Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bence Jones protein and amyloid. Studies on the relationship between naturally occurring human anti-Bence Jones protein antibodies and Bence Jones protein with amyloid].
    Sellin D; Haferkamp O
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 147(3):173-89. PubMed ID: 4876308
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects].
    Lovisetto P; Frascisco M; Gilardi E; Marchi L; Mairano D
    Minerva Med; 1980 Jun; 71(25):1801-13. PubMed ID: 6774298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V; Mangione P; Merlini G
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid A in systemic amyloidosis associated with cancer.
    Husby G; Marhaug G; Sletten K
    Cancer Res; 1982 Apr; 42(4):1600-3. PubMed ID: 7060030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin-related (AL) amyloidosis.
    Husby G
    Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.